Literature DB >> 28756226

Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.

Santosh Kumar1, Namita Sinha2, Kelli A Gerth2, Mohammad A Rahman2, Murali M Yallapu2, Narasimha M Midde2.   

Abstract

Cytochrome P450 (CYP) enzymes metabolize the majority of xenobiotics and are mainly found in hepatic and some extra-hepatic cells. However, their presence and functional role in exosomes, small extracellular vesicles that are secreted from various cells into extracellular fluids including plasma, is unknown. In this study, we analyzed the expression and biological activity of CYP enzymes in human plasma exosomes. First, we optimized isolation of plasma exosomes and characterized them for their physical properties and quality. The results showed that the purity of exosomes (<200 nm) improved upon prior filtration of plasma using a 0.22 micron filter. We then analyzed the relative level of exosomal CYP mRNAs, proteins, and enzyme activity. The results showed that the relative level of CYP enzymes in exosomes is higher than in plasma, suggesting their specific packaging in exosomes. Of the seven CYP enzymes tested, the mRNA of CYP1B1, CYP2A6, CYP2E1, and CYP3A4 were detectable in exosomes. Interestingly, the relative level of CYP2E1 mRNA was >500-fold higher than the other CYPs. The results from the Western blot showed detectable levels of CYP1A1, CYP1B1, CYP2A6, CYP2E1, and CYP3A4. Our results also demonstrated that exosomal CYP2E1 and CYP3A4 show appreciable activity relative to their respective positive controls (CYP-induced baculosomes). Our results also showed that CYP2E1 is expressed relatively higher in plasma exosomes than hepatic and monocytic cells and exosomes derived from these cells. In conclusion, this is the first evidence of the specific packaging and circulation of CYP enzymes, especially CYP2E1, in human plasma exosomes. The findings have biological and clinical significance in terms of their implications in cellular communications and potential use of plasma exosomal CYPs as biomarkers.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CYP2E1; Cytochrome P450; Exosomes; Plasma

Mesh:

Substances:

Year:  2017        PMID: 28756226      PMCID: PMC5901973          DOI: 10.1016/j.bbrc.2017.07.145

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate.

Authors:  Bryan D Marks; Ronald W Smith; Heidi A Braun; Tony A Goossens; Marie Christenson; Mary S Ozers; Connie S Lebakken; Olga V Trubetskoy
Journal:  Assay Drug Dev Technol       Date:  2002-11       Impact factor: 1.738

Review 2.  Exosomes: from biogenesis and secretion to biological function.

Authors:  Sascha Keller; Michael P Sanderson; Alexander Stoeck; Peter Altevogt
Journal:  Immunol Lett       Date:  2006-10-17       Impact factor: 3.685

Review 3.  CYP1B1: a unique gene with unique characteristics.

Authors:  Muneeb A Faiq; Rima Dada; Reetika Sharma; Daman Saluja; Tanuj Dada
Journal:  Curr Drug Metab       Date:  2014       Impact factor: 3.731

4.  Isolation of biologically-active exosomes from human plasma.

Authors:  Laurent Muller; Chang-Sook Hong; Donna B Stolz; Simon C Watkins; Theresa L Whiteside
Journal:  J Immunol Methods       Date:  2014-06-18       Impact factor: 2.303

Review 5.  Exosomes as intercellular signalosomes and pharmacological effectors.

Authors:  Michel Record; Caroline Subra; Sandrine Silvente-Poirot; Marc Poirot
Journal:  Biochem Pharmacol       Date:  2011-03-01       Impact factor: 5.858

Review 6.  Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.

Authors:  Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-02       Impact factor: 4.481

7.  Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.

Authors:  Vikas K Verma; Haiyang Li; Ruisi Wang; Petra Hirsova; Malek Mushref; Yaming Liu; Sheng Cao; Patricia C Contreras; Harmeet Malhi; Patrick S Kamath; Gregory J Gores; Vijay H Shah
Journal:  J Hepatol       Date:  2015-11-26       Impact factor: 25.083

Review 8.  Cigarette smoking, metabolic activation and carcinogenesis.

Authors:  Akiyoshi Nishikawa; Yukio Mori; In-Seon Lee; Takuji Tanaka; Masao Hirose
Journal:  Curr Drug Metab       Date:  2004-10       Impact factor: 3.731

9.  Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method.

Authors:  Narasimha M Midde; Mohammad A Rahman; Chetan Rathi; Junhao Li; Bernd Meibohm; Weihua Li; Santosh Kumar
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

10.  Regulation of cytochrome P450 2e1 expression by ethanol: role of oxidative stress-mediated pkc/jnk/sp1 pathway.

Authors:  M Jin; A Ande; A Kumar; S Kumar
Journal:  Cell Death Dis       Date:  2013-03-21       Impact factor: 8.469

View more
  24 in total

1.  Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers.

Authors:  Sunitha Kodidela; Yujie Wang; Benjamin J Patters; Yuqing Gong; Namita Sinha; Sabina Ranjit; Kelli Gerth; Sanjana Haque; Theodore Cory; Carole McArthur; Anil Kumar; Jim Y Wan; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-08       Impact factor: 4.147

Review 2.  Emerging role of extracellular vesicles in liver diseases.

Authors:  Harmeet Malhi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

3.  Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers.

Authors:  Sunitha Kodidela; Sabina Ranjit; Namita Sinha; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

Review 4.  Extracellular Vesicles: Intercellular Mediators in Alcohol-Induced Pathologies.

Authors:  Mohammad A Rahman; Benjamin J Patters; Sunitha Kodidela; Santosh Kumar
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-06       Impact factor: 4.147

5.  Choosing the right pharmacotherapeutic strategy for HIV maintenance in patients with alcohol addiction.

Authors:  Sunitha Kodidela; Santosh Kumar
Journal:  Expert Opin Pharmacother       Date:  2019-02-06       Impact factor: 3.889

6.  Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.

Authors:  Andrew Rowland; Warit Ruanglertboon; Madelé van Dyk; Dhilushi Wijayakumara; Linda S Wood; Robyn Meech; Peter I Mackenzie; A David Rodrigues; Jean-Claude Marshall; Michael J Sorich
Journal:  Br J Clin Pharmacol       Date:  2018-11-16       Impact factor: 4.335

7.  In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV replication.

Authors:  Mohammad A Rahman; Yuqing Gong; Santosh Kumar
Journal:  Toxicol Lett       Date:  2018-04-22       Impact factor: 4.372

Review 8.  Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues.

Authors:  Rolf Teschke; Jack Uetrecht
Journal:  Ann Transl Med       Date:  2021-04

9.  Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing.

Authors:  Warit Ruanglertboon; Michael J Sorich; Ashley M Hopkins; Andrew Rowland
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

Review 10.  Extracellular vesicles: Roles and applications in drug-induced liver injury.

Authors:  David S Umbaugh; Hartmut Jaeschke
Journal:  Adv Clin Chem       Date:  2020-10-01       Impact factor: 5.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.